For AI to control a PC and take actions on behalf of the user, it must first be granted access to see what’s on the screen.

Software and web developer jobs pay very well, but you'll need to know how to code. Here are 22 websites that will help you ...

The US federal government is cutting support for a major federal cyber threat information-sharing program. In a public statement published on September 29, the US Cybersecurity and Infrastructure ...

SPARTANBURG, S.C. (WSPA) — The Spartanburg Academic Movement and Movement 2030 announced the launch of Big Mo, a college access program for high school students. Starting October 1, public high school ...

Microsoft has cut off the Israel Ministry of Defense’s access to some of its tech and services after an internal investigation found the organization appeared to be using its tech to store ...

Microsoft has reportedly cut off Israeli military access to its Azure cloud and AI technology that was being used to monitor millions of Palestinian civilians' phone calls, according to a new report ...

Microsoft has blocked an Israeli military unit from using some of its technology services after the company found evidence supporting a report that the tech was being used for surveillance of ...

Windows 10 users in the European Economic Area can now receive an extra year of security updates without using reward points or buying additional storage. Jibin is a tech news writer based in ...

Microsoft has cut off some services to a unit in Israel’s Defense Ministry after investigating allegations that it was using Microsoft cloud products for the mass surveillance of Palestinians. In a ...

Microsoft is launching a new Windows AI Labs program. It offers early access to AI features, starting with Paint. The program is available only to select users via an invite in Paint. Those of you who ...

Microsoft Paint is the first app to get new experimental AI features. Microsoft Paint is the first app to get new experimental AI features. is a senior editor and author of Notepad, who has been ...

Sanofi’s long and winding path to get its investigational multiple sclerosis drug over the regulatory finish line has taken another turn with the FDA's move to delay its approval decision on the ...